Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials.

Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials.

BACKGROUND: Pharmacological inhibitors of vascular endothelial growth factor (VEGF) receptors, like vatalanib, have been tested in randomised trials (CONFIRM (Colorectal Oral Novel therapy For the Inhibition of Angiogenesis and Retarding of Metastases) 1 and 2) in colorectal cancer showing activity...

Full description

Bibliographic Details
Main Authors:	Giatromanolaki, A, Koukourakis, M, Sivridis, E, Gatter, K, Trarbach, T, Folprecht, G, Shi, M, Lebwohl, D, Jalava, T, Laurent, D, Meinhardt, G, Harris, A
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy.
by: Koukourakis, M, et al.
Published: (2011)

A Phase I, open-label study with escalating doses of intravenous PTK787/ZK 222584, a multi-VEGF receptor inhibitor, followed by multiple oral daily dosing to assess the absolute bioavailability of PTK787/ZK 222584 after single and multiple doses in advanced cancer patients
by: Pavel, M, et al.
Published: (2005)

Randomized, placebo-controlled, phase III study of first-line oxaliplatin-based chemotherapy plus PTK787/ZK 222584, an oral vascular endothelial growth factor receptor inhibitor, in patients with metastatic colorectal adenocarcinoma.
by: Hecht, JR, et al.
Published: (2011)

Phase 1 Study of Combination Treatment with PTK 787/ZK 222584 and Cetuximab for Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics Analysis
by: Marlies H.G. Langenberg, et al.
Published: (2010-02-01)

A phase II study of PTK787 in metastatic melanoma patients
by: Corrie, P, et al.
Published: (2008)

Inclusion of vasculature-related variables in the Dukes staging system of colon cancer.
by: Koukourakis, M, et al.
Published: (2005)

Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
by: Sivridis, E, et al.
Published: (2002)

High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC).
by: Koukourakis, M, et al.
Published: (2013)

BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1alpha pathway and prognosis.
by: Giatromanolaki, A, et al.
Published: (2008)

Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
by: Koukourakis, M, et al.
Published: (2006)

Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma.
by: Koukourakis, M, et al.
Published: (2005)

Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1alpha expression.
by: Giatromanolaki, A, et al.
Published: (2006)

Autophagy and hypoxia in colonic adenomas related to aggressive features.
by: Giatromanolaki, A, et al.
Published: (2013)

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia.
by: Koukourakis, M, et al.
Published: (2010)

Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas.
by: Giatromanolaki, A, et al.
Published: (2010)

Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin.
by: Giatromanolaki, A, et al.
Published: (2003)

Expression of phosphorylated (activated) receptors of vascular endothelial growth factor (VEGFR2/KDR) in colorectal cancer
by: Giatromanolaki, A, et al.
Published: (2007)

Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis.
by: Sivridis, E, et al.
Published: (2002)

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.
by: Koukourakis, M, et al.
Published: (2003)

The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer.
by: Giatromanolaki, A, et al.
Published: (2008)

LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer.
by: Koukourakis, M, et al.
Published: (2005)

Overexpression of LC3A autophagy protein in follicular and diffuse large B-cell lymphomas.
by: Giatromanolaki, A, et al.
Published: (2013)

BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer.
by: Giatromanolaki, A, et al.
Published: (2004)

Pyruvate Dehydrogenase and Pyruvate Dehydrogenase Kinase Expression in Non Small Cell Lung Cancer and Tumor-Associated Stroma
by: Michael I. Koukourakis, et al.
Published: (2005-01-01)

A phase 2 study of vatalanib in metastatic melanoma patients.
by: Cook, N, et al.
Published: (2010)

Data showing the circumvention of oxaliplatin resistance by vatalanib in colon cancer
by: Kenneth K.W. To, et al.
Published: (2016-06-01)

Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer.
by: Giatromanolaki, A, et al.
Published: (2002)

DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer.
by: Giatromanolaki, A, et al.
Published: (2003)

Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer.
by: Koukourakis, M, et al.
Published: (2004)

Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
by: Koukourakis, M, et al.
Published: (2003)

Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins.
by: Giatromanolaki, A, et al.
Published: (2008)

Hypoxia inducible factors 1alpha and 2alpha are associated with VEGF expression and angiogenesis in gallbladder carcinomas.
by: Giatromanolaki, A, et al.
Published: (2006)

c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent.
by: Giatromanolaki, A, et al.
Published: (2004)

Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation.
by: Giatromanolaki, A, et al.
Published: (2008)

Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer.
by: Koukourakis, M, et al.
Published: (2006)

Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer.
by: Giatromanolaki, A, et al.
Published: (2007)

C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1alpha gene define HIF-1alpha protein expression in non-small cell lung cancer.
by: Koukourakis, M, et al.
Published: (2006)

Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
by: Giatromanolaki, A, et al.
Published: (2003)

Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis.
by: Giatromanolaki, A, et al.
Published: (2003)

LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas.
by: Sivridis, E, et al.
Published: (2010)